Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
6.39
+0.56 (9.71%)
Jul 21, 2026, 9:50 AM EDT - Market open
Edesa Biotech Employees
Edesa Biotech had 17 employees as of September 30, 2025. The number of employees increased by 1 or 6.25% compared to the previous year.
Employees
17
Change (1Y)
1
Growth (1Y)
6.25%
Revenue / Employee
n/a
Profits / Employee
-$614,343
Market Cap
56.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 17 | 1 | 6.25% |
| Sep 30, 2024 | 16 | 0 | - |
| Sep 30, 2023 | 16 | 0 | - |
| Sep 30, 2022 | 16 | 0 | - |
| Sep 30, 2021 | 16 | 4 | 33.33% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 76 |
| Seres Therapeutics | 66 |
| BeyondSpring | 44 |
| Boundless Bio | 28 |
| INmune Bio | 21 |
| Filana Therapeutics | 20 |
| Instil Bio | 17 |
| MiNK Therapeutics | 15 |
EDSA News
- 18 days ago - Edesa Biotech files to sell 729,241 common shares for holders - TheFly
- 21 days ago - Edesa Biotech reinstated with a Buy at Brookline - TheFly
- 5 weeks ago - Edesa Biotech announces $3.5M private placement - TheFly
- 5 weeks ago - Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors - GlobeNewsWire
- 6 weeks ago - Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury - GlobeNewsWire
- 2 months ago - Edesa Biotech Inc trading resumes - TheFly
- 2 months ago - Edesa Biotech Inc trading halted, volatility trading pause - TheFly
- 2 months ago - Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference - GlobeNewsWire